Trials / Completed
CompletedNCT00913718
To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting Conditions
Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Health Adult Males Under Fasting Conditions Following Administration of a 40 mg Dose
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride capsules (Pulvules) in healthy adult males under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluoxetine Hydrochloride 20 mg Capsules (Geneva Pharmaceutical, Inc.) | |
| DRUG | Prozac Fluoxetine Hydrochloride 20 mg Capsules (Dista) |
Timeline
- Start date
- 1996-06-01
- Primary completion
- 1996-07-01
- Completion
- 1996-07-01
- First posted
- 2009-06-04
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00913718. Inclusion in this directory is not an endorsement.